Media highlights.2003: Executive Director Frances Smith discussed interest-free offers from retailers in a report aired on 24 stations nationwide in December, including WJLA WJLA Washington DC area television station; JLA comes from founder Joseph L. Allbritton in Washington. 2004: Smith was quoted in the San Francisco Chronicle The San Francisco Chronicle was founded in 1865 as The Daily Dramatic Chronicle by teenage brothers Charles de Young and Michael H. de Young.[2] The paper grew along with San Francisco to become the largest circulation newspaper on the West Coast of the on food scares on Jan. 4. Smith's op-ed "Fight over Commission bid to govern commercial speech" about consumer health information appeared in the Jan. 19 EU Reporter. Policy Analyst Barbara Rippel's op-ed, "Even trade politics can be local," about the US-Australia free trade agreement, appeared in the Jan. 29 Washington Times. Rippel's op-ed "Balance your energy budget!" appeared in Consumers' Research. Smith's op-ed, "Mercantilism mercantilism (mûr`kəntĭlĭzəm), economic system of the major trading nations during the 16th, 17th, and 18th cent., based on the premise that national wealth and power were best served by increasing exports and collecting Today: When politics trumps free trade, consumers lose," appeared at National Review Online Feb. 12. Rippel's op-ed, "Common market doesn't mean 'collective preferences'" appeared in the Feb. 16 EU Reporter. Policy Analyst James Plummer's op-ed, "Label Wars" appeared in Consumers' Research magazine. Plummer was quoted by Washington Internet Daily Mar. 9 concerning the Alliance for Digital Progress. Smith's participation on a FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. panel in March concerning prescription drug reimportation re·im·port tr.v. re·im·port·ed, re·im·port·ing, re·im·ports To bring back into a country (goods made from its exported raw materials). re·im was covered in Drug Industry Daily Mar. 22 and Washington Drug Letter Mar. 29. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion